Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects.

This study has been withdrawn prior to enrollment.
(Compound terminated)
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00536497
First received: September 25, 2007
Last updated: February 12, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given